![]() |
|
|
My Amedeo
FAQ
Privacy
About
|
For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF |
| Prostate Cancer |
|
Free Subscription
2 BJU Int |
Retrieve available abstracts of this week’s articles:
HTML format |
| Single Articles |
AMEDEO Prostate Cancer is free of charge.
Safety and feasibility of telesurgical robot assisted radical prostatectomy:
prospective pilot study.
BJU Int. 2026;138:1115-1122.
PubMed
Abstract available
Global trends in urological cancers: an analysis of the global burden of disease
study 2023.
BJU Int. 2026;138:1034-1042.
PubMed
Abstract available
A multilevel intervention to improve adherence to prostate cancer active
surveillance versus usual care: results from a pilot randomized controlled trial.
BMC Cancer. 2026;26:1314.
PubMed
Abstract available
Assessing germline genetic testing patterns, awareness, and adherence to
guidelines among lebanese prostate cancer patients.
BMC Urol. 2026;26:277.
PubMed
Abstract available
Long-term fatigue based on the EORTC QLQ-C30 up to five years after radiotherapy
and its trajectories in men diagnosed with non-metastatic prostate cancer in the
international REQUITE study.
Br J Cancer. 2026 Nov 4. doi: 10.1038/s41416-026-03644.
PubMed
Abstract available
Editor's Note: A Novel HSP90 Inhibitor Delays Castrate-Resistant Prostate Cancer
without Altering Serum PSA Levels and Inhibits Osteoclastogenesis.
Clin Cancer Res. 2026;32:5002.
PubMed
Treatment Effect of Perioperative (Neoadjuvant and Adjuvant) Apalutamide plus
Androgen-deprivation Therapy Versus Radical Prostatectomy Alone in Patients with
High-risk Localized or Locally Advanced Prostate Cancer from the PROTEUS
Substudy.
Eur Urol. 2026 Oct 24:S0302-2838(26)02476-0. doi: 10.1016/j.eururo.2026.
PubMed
Abstract available
Development and Validation of a Multimodal Artificial Intelligence-derived
Digital Pathology-based Biomarker Predicting Metastasis Among Patients with
Biochemical Recurrence After Radical Prostatectomy in NRG/RTOG Trials.
Eur Urol. 2026;90:470-478.
PubMed
Abstract available
Intraductal Carcinoma of the Prostate Is Associated With Improved Efficacy of
Olaparib Combined With Novel Hormonal Therapy in Metastatic Castration-Resistant
Prostate Cancer.
Int J Cancer. 2026 Nov 3. doi: 10.1002/ijc.70806.
PubMed
Abstract available
Magnetic Resonance Imaging Findings and Prostate-Specific Antigen Density-Based
Risk Stratification for Deferring a Separate Preoperative Biopsy in Candidates
for Holmium Laser Enucleation of the Prostate.
Int J Urol. 2026;33:e70694.
PubMed
Abstract available
Beyond Surgical Technique: Prostate Cancer Assessment and Treatment Sequencing
Before HoLEP.
Int J Urol. 2026;33:e70698.
PubMed
External Validation of Existing Nomograms on Indian Prostate Biopsy Data.
Int J Urol. 2026;33:e70690.
PubMed
Abstract available
Artificial Intelligence-enhanced Identification of Incidental Findings in
Prostate MRI.
Invest Radiol. 2026;61:875-886.
PubMed
Abstract available
The Global Theranostics Access Gap: Real-World Disparities in PSMA PET/CT and
(177)Lu-PSMA Therapy Between Centers in Brazil and Europe.
J Nucl Med. 2026 Aug 20:jnumed.126.273029. doi: 10.2967/jnumed.126.273029.
PubMed
Abstract available
Fully Automated Segmentation of [(18)F]FDG and [(68)Ga]/[(18)F]PSMA PET/CT Images
via Data-Centric Deep Learning.
J Nucl Med. 2026 Sep 30:jnumed.126.272852. doi: 10.2967/jnumed.126.272852.
PubMed
Abstract available
PARP and Androgen-Signaling Inhibition in Metastatic Prostate Cancer. Reply.
N Engl J Med. 2026;395:1874-1875.
PubMed
PARP and Androgen-Signaling Inhibition in Metastatic Prostate Cancer.
N Engl J Med. 2026;395:1872-1874.
PubMed
PARP and Androgen-Signaling Inhibition in Metastatic Prostate Cancer.
N Engl J Med. 2026;395:1873.
PubMed
PARP and Androgen-Signaling Inhibition in Metastatic Prostate Cancer.
N Engl J Med. 2026;395:1872-1873.
PubMed
Mutational processes in prostate cancer.
Nat Rev Urol. 2026 Oct 30. doi: 10.1038/s41585-026-01215.
PubMed
Disassembly of PKA holoenzyme organization marks prostate cancer progression.
Oncogene. 2026 Nov 3. doi: 10.1038/s41388-026-04042.
PubMed
Abstract available
Multifocal Prostate-specific Membrane Antigen-avid Cholangiocarcinoma Mimicking
Prostate Cancer Metastases.
Radiol Imaging Cancer. 2026;8:e260467.
PubMed
Rising Active Surveillance/Observation Rates and Regimen Intensification in Young
Men: A Retrospective Cohort Study of National Commercial Health Insurance Claims
Data.
Urology. 2026;216:53-58.
PubMed
Abstract available
Thank you for your interest in scientific medicine.